[Clinical and laboratory grounds for using solcoseryl in high-risk patients].

@article{Kuznetsova2000ClinicalAL,
  title={[Clinical and laboratory grounds for using solcoseryl in high-risk patients].},
  author={Oxana I. Kuznetsova and Ignat I. Kolesnichenko and A D Khalikov and Georgy Moiseevich Manikhas and Gennady Rodionov},
  journal={Vestnik khirurgii imeni I. I. Grekova},
  year={2000},
  volume={159 5},
  pages={75-7}
}
In 56 patients aged from 58 to 82 years with the III and IV degrees of risk operated upon for malignant tumors of organs of the thoracic and abdominal organs Solcoseryl was included in the complex of anesthesia measures. It was given intravenously or as inhalation in dosage of 1000 mg. It was found that using Solcoseryl considerably reduced the amount of… CONTINUE READING